NIH researchers are in the very early stages of studying a drug that may alleviate depression by repairing the brain cells responsible for controlling an individual’s mood. The drug seems to help patients who are not helped by the standard treatments available today, and the researchers report that it may start helping some patients in a little more than an hour.

Read the story.